New Partnership: ARCC joins CCTG trial aimed at protecting cancer patients from COVID-19
The Canadian Cancer Trials Group (CCTG) has launched a new trial focusing on strengthening the immune system in cancer patients, CCTG IC.8: Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO). Funding and in-kind support, valued (more…)